Evaluation of Hepatic Function Impairment on the Pharmacokinetics of LEE011

Clinical trial NCT02388620 · COMPLETED

Trial details

NCT number: NCT02388620
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Normal Hepatic Function Impaired Hepatic Function

Start date: 2015-03-25
Primary completion: 2017-01-09
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.